MTOR and hepatocellular carcinoma: Furthermore, these metabolites further reinforce the activation of the MAPK/mTOR pathway, forming a self-feeding vicious circle that creates a dominant pro-proliferation environment for HCC cells, posing significant challenges in the treatment of HBV-related HCC.